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Abstract
Introduction: Chagas disease is a major public health problem that is endemic in Brazil and Latin America. This study aimed to 
determine the socioeconomic, demographic, and clinical characteristics of 171 patients (mean age, 45 years; female, 65%) with Chagas 
disease at Hospital Universitário de Brasília, Federal District, Brazil. Methods: We implemented this cross-sectional study using a 
clinical epidemiological questionnaire, electrocardiography, echocardiography, and quantitative detection of Trypanosoma cruzi 
DNA in blood using qRT-PCR. Results: Among the patients, 26.3% had a full elementary education, and 13.2% were illiterate. 
Most (63.6%) were economically classified as class C, and 51.5% were born in Bahia state. A total of 62.0% participants reported 
previous contact with the triatomine bug. The clinical forms of the disease were indeterminate (69.51%), cardiac (15.24%), digestive 
(10.37%), and mixed (4.88%). The most common electrocardiographic abnormality was complete right bundle branch block in 
association with a divisional anterosuperior block. Only 14.6% of the patients complied with benznidazole medication for at least 
60 days, and 164 of them were assessed by echocardiography. The parasite load was positive in 56% of the patients. Conclusions: 
Chagas disease affected mostly women, with the indeterminate chronic form of the disease.
Keywords: Epidemiological profile. University hospital. Chagas disease.
INTRODUCTION
Chagas disease (CD) remains a major public health issue in 
Brazil and Latin America1-3. About 2 - 3 million individuals in 
Brazil are infected and ~6,000 deaths are recorded annually1, 
whereas 8 - 10 million are infected in Latin America4. 
Although CD has been considered a rural disease, its 
geographical distribution has recently widened, possibly due 
to the success of programs to control vector transmission in 
endemic areas as well as regional and international migration5. 
The disease has also spread to the USA and some European 
countries5,6. Although this might be associated with the 
distribution of the chronic form of CD, other serious conditions 
associated with undetermined and cardiac and digestive forms, 
might impose a cost burden on health systems. In addition, 
transmission through other routes such as maternal and oral, 
and reactivation in immunosuppressed individuals could be 
involved. Few systematic, population-based studies have 
hindered an estimated evaluation of the magnitude of CD in 
Brazil. Until the 1960s1, CD typically affected younger manual 
laborers in rural areas who were not well-educated, and possibly 
infected via vector transmission. The estimated prevalence of 
CD at that time was 4.2% of the total population of 6.5 million, 
and mostly involved rural areas1. However, CD has now spread 
to urban areas of Brazil as a result of migration and intensified 
along with urban-industrial development since the 1970s. In 
fact, an estimated 65% of the population with CD in Brazil is 
thought to currently reside in urban areas7. 
The migration and urbanization phenomena have improved 
the survival rates of patients affected by the disease. Development 
has improved housing conditions, decreased rural populations, 
and granted more access to health care systems where patients 
can access cardiopathy-specific medications, permanent 
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pacemaker implants, cardiac transplantation, and stricter blood 
donor screens8. The urbanization of Brazil and the increased 
survival of individuals infected with Trypanosoma cruzi have 
led to the emergence of associations and interactions with other 
chronic diseases such as hypertension, diabetes mellitus and 
immunosuppressed states such as HIV and transplantation that 
promote CD reactivation4.
The social costs are very high because CD affects patients 
of reproductive age, and therapeutic options as well as research 
investment are limited. Therefore, a study of the characteristics 
of patients with CD and attention from public health agencies 
are justified. Appropriate patient follow-up and the creation of 
a health care network adapted to this new reality have become 
essential, especially when considering that CD can cause severe 
cardiopathy. 
Therefore, we aimed to determine the socioeconomic, 
demographic and clinical characteristics, echocardiographic 
findings and parasite loads of patients with CD treated at Brasília 
University Hospital (HUB). The patients were derived from a 
cohort selected for an evaluation of factors that could predict 
progression to cardiac CD.
METHODS
This descriptive study included 171 patients aged > 18 
years. All were diagnosed with CD according to the criteria of 
the 2015 Brazilian Consensus on CD, had positive serological 
chemiluminescence and indirect hemagglutination findings at the 
cardiology and infectious disease units at HUB, and were followed 
up between April 2016 and December 20179. The patients were 
invited to enroll in the study during routine clinical appointments 
and were included after completing structured a clinical 
epidemiological questionnaire and undergoing a thorough clinical 
evaluation, routine hematological and biochemical laboratory 
tests, electrocardiography and conventional echocardiography. 
Blood samples were collected to identify T. cruzi DNA using 
quantitative real-time polymerase chain reaction (qRT-PCR)10. 
The evaluated variables included sociodemographic data 
(age, sex, education level, marital status, household income, 
employment status, economic classification11, location of 
residence, probable location of infection), clinical history (current 
complaints), lifestyle habits (smoking, alcohol consumption, 
sedentary lifestyle), comorbidities, medications, previous 
benznidazole treatment and the findings of a physical examination. 
The clinical forms of CD were classified according to the 
criteria published by the 2015 Brazilian Consensus on CD9. 
Echocardiography proceeded using a TUS-A 400 ultrasound 
System (Toshiba Medical Systems Corp., Otawara, Japan). 
The biplane method of disks (modified Simpson rule) is 
the currently recommended 2D method of left ventricular 
ejection fraction (LVEF) assessment recommended by the 
American Society of Echocardiography and the European 
Association of Cardiovascular Imaging12. Diastolic function 
was evaluated from mitral inflow E/A profiles and annular 
tissue Doppler curves (e’/a’) as recommended by the American 
Society of Echocardiography and the European Association of 
Cardiovascular Imaging13.
The Ethics Committee of the School of Medicine at Brasilia 
University approved the study (date, 04/29/2016; protocol 
number, 1.521.680), which proceeded in accordance with the 
Helsinki Declaration of 1964, as revised in 1975, 1983, 1989, 
1996, and 2000. All included patients provided written, informed 
consent to participate in all procedures associated with the study.
Statistical Analysis
Statistical analyses included descriptions of the data 
according to the variables of interest. Categorical data are 
represented as absolute and relative frequencies and quantitative 
data are shown as measures of central tendencies and dispersion. 
The normality of distributions at a 5% level of statistical 
significance was analyzed using Kolmogorov-Smirnov tests. 
The database was created and analyzed using the Statistical 
Package for the Social Sciences (SPSS) version 17.0 (SPSS 
Inc., Chicago, IL, USA).
RESULTS 
Among 164 (95.91%) of the 171 patients who were 
evaluated by conventional echocardiography, 158 (96%) of them 
volunteered to participate in qRT-PCR tests for T. cruzi DNA. 
Table 1 shows that most of the patients were female, (n = 112, 
65%) and the median age of the entire cohort was 45 (range 24 
- 74) years. Overall, 88 (51.5%) patients were originally from 
Bahia state in northeast Brazil, whereas 108 (63.2%) resided in 
the Federal District. Most patients had some education, but 23 
(13.2%) were illiterate. Most patients were married or were in 
a stable relationship (n = 116, 67.8%). Regarding self-reported 
ethnicity, 60% (n = 103) were mixed/Pardo (Moreno), 19.9% (n 
= 34) were Caucasian and 13.5% (n = 23) were Afro-Brazilian. 
Based on economic classification, most patients were class C 
(n = 77, 63.7%), and a minority (n = 6, 63.5%) were class E. 
At the time of the interview, 94 (55%) patients stated that they 
were employed, mostly in domestic jobs or assisting in general 
services. Among lifestyle habits, 133 (77.8%) patients did not 
consume alcoholic beverages, 12 (7%) smoked and 88 (51%) 
had sedentary lifestyles. Of those who were employed, work 
required a considerable amount of walking (6%), and heavy 
physical activities (49%). 
Table 1 shows the distribution of the epidemiological 
characteristics associated with clinical forms. At the time 
of the interview, 137 (80%) patients lived in urban areas, 
160 (93.6%) lived in rural areas and 129 (75.0%) lived in 
“wattle and daub” dwellings. A total of 106 (62.0%) had 
previous contact with the triatomine bug, and 28 (49.1%) 
had relatives aged < 40 years with cardiac problems. 
Comorbidities in the 171 patients comprised arterial 
hypertension in 37 (21.6%), dyslipidemia in 35 (20.5%), 
depression/anxiety in 27 (15.8%), and diabetes in 9 (7.8%). 
Medications prescribed to the patients included antidiabetics, 
lipid-lowering drugs, antidepressants and others. The 
most frequent medications reported by 33 (19%) patients 
were angiotensin-converting enzyme inhibitors and renin-
angiotensin system blockers. (Table 2). With respect to 
benznidazole (BNZ), 59 (34.5%) patients were treated and 
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TABLE 1: Distribution of social and demographic characteristics of 171 participants according to clinical forms of Chagas disease at HUB, Brasília.
Indeterminate Cardiac Mixed Digestive P*
Sex M 31 (26.7%) 14 (48.3%) 5 (62.5%) 9 (50.0%) 0.014
F 85 (73.3%) 15 (51.5%) 3 (37.5%) 9 (50.0%)
Median age (IQR) 45.00 (12.00) 45.00 (16.00) 50.00 (14.00) 45.50(14.00) 0.647
Illiterate 16 (13.8%) 2 (6.9%) 2 (25.0%) 3 (16.7%) 0.108
Elementary 1 21 (18.1%) (13.8%) 0.0 1 (5.6%)
Elementary 2 23 (19.8%) 11 (37.9%) 5 (62.5%) 6 (33.3%)
Incomplete high school 20 (17.2%) 4 (13.8%) 0.0 3 (16.7%)
Completed high school 22 (19.0%) 6 (20.7%) 1 (12.5%) 4 (22.5%)
Completed university 14 (12.5%) 2 (6.9%) 0.0 1 (5.6%)
Caucasian 25 (21.6%) 2 (6.9%) 3 (37.5%) 4 (22.5%)
Afro-Brazilian 15 (12.9%) 7(24.1%) 0.0 1 (5.6%) 0.503
Asian 2 (1.7%) 3 (10.3%) 0.0 1 (5.6%)
African 69 (59.5%) 17 (58.6%) 5 (62.5%) 12 (66.7)
Indigenous 1 (0.9%) 0.0 0.0 0.0
Unknown 3 (2.6%) 0.0 0.0 0.0
Declined to inform 1 (0.9%) 0.0 0.0 0.0
A 1 (0.9%) 0.0 0.0 0.0 0.858
B 18 (15.5%) 3 (10.3%) 0.0 2 (11.1%)
Economic level C 73 (62.9%) 20 (69.0%) 5 (62.5%) 11 (61.1%)
D 19 (16.4%) 6 (20.7%) 3 (37.5%) 4 (22.2%)
E 5 (4.3%) 0.0 0.0 1 (5.6%)
  Employed 66 (56.9%) 12 (41.4%) 4 (50.0%) 12 (66.7%) 0.348
  Domestic worker 20 (17.5%) 0 1 (12.5%) 3 (15.8%) 0.546
General services 15 (14.3%) 2 (6.9%) 2 (25.0%) 4 (22.2%)
Trades services 17 (14.7%) 6 (20.7%) 0.0 2 (11.1%)
Missionary 0.0 1 (3.4%) 0.0 1 (5.3%)
Health care 
2 (1.7%) 0.0 0.0 0.0
Teacher 4 (3.4%) 0.0 0.0 1 (5.6%)
Pensioner/retired 3 (2.6%) 0.0 0.0 1 (5.6%)
Government employee 2 (1.7%) 0.0 0.0 1 (5.6%)
Rural worker 5 (4.3%) 4 (13.8%) 1 (12.5%) 1 (5.6%)
Homemaker 5 (4.3%) 2 (6.9%) 0.0 1 (5.6%)
Rural residence 20 (17.2%) 7 (24.1%) 4 (50.0%) 3 (16.7%) 0.129
Urban residence 96 (82.8%) 22 (75.9%) 4 (50.0%) 15 (83.3%)
Previously bitten by triatomine 69 (59.5%) 21 (74.2%) 6 (75.0%) 10 (55.6%) 0.760
Family history of Chagas disease 84 (72.4%) 22 (75.9%) 4 (50.0%) 13 (72.2%) 0.465
Lived in rural area 107 (92.2%) 28 (96.6%) 8 (100.0%) 17 (94.4%) 0.805
Median time outside endemic area 
(years) 20.00 (31.00) 20.00 (30.00) 10.00 (35.00) 26.00 (18.00) 0.262
Abbreviations: Domestic employment, housekeeper, child caregiver, house cleaner, gardener; F: female; median (interquartile interval); Freq: frequency; General 
services, cook, kitchen assistant, firefighter, maid, kitchen maid, street cleaner, concierge, security; Health care, assistant, nursing assistant, lab technician; HUB: 
Brasília University Hospital; M: male; Trades services, attendant, treasurer, clerk, hairdresser, merchant, deliverer, waiter, manicurist, assembler, repository, cab 
driver. *Pearson chi-square tests with Monte Carlo correction for qualitative variables and Kruskal-Wallis tests for quantitative variables. 
112 (65.5%) were not. Among those treated with BNZ, 24 
(14%) completed the treatment course and 15 (8.8%) did not. 
All 171 patients were assessed by electrocardiography. The 
most prevalent electrocardiographic abnormality associated with 
cardiac and mixed forms, was complete right bundle branch 
block (RBBB) associated with a divisional anterosuperior block 
(ASDB) in 11 (6%) patients, complete right bundle branch 
block (RBBB) in 7 (4%), and first-degree atrioventricular 
block in 3 (2%). The clinical forms of CD were indeterminate, 
cardiac, digestive and mixed in 114 (69.51%), 25 (15.24%), 
17 (10.37%) and 8 (4.88%) patients, respectively. The 
distribution of the cardiac forms was A (n = 10), B1 (n = 9), 
B2 (n = 4), and C (n = 12). Echocardiographic abnormalities 
were associated with indeterminate CD in 22 (19.64%) 
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TABLE 2: Distribution of clinical characteristics according to the clinical form of Chagas disease at HUB, Brasília.
Indeterminate Cardiac Mixed Digestive P*
  Hypertension 26 (22.4%) 5 (17.2%) 2 (25.0%) 4 (22.2%) 0.941
  Dyslipidemia 30 (25.9%) 2 (6.9%) 2 (25.0%) 1 (5.6%) 0.240
  Depression 12 (10.3%) 2 (6.9%) 0.0 1 (5.6%) 0.904
Anxiety 8 (6.9%) 2 (6.9%) 1 (12.5%) 1 (5.6%) 0.957
Diabetes 9 (7.8%) 0.0 0.0 0.0 0.932
Hyperthyroidism 3 (2.6%) 1 (3.4%) 0.0 0.0 0.817
Gastritis 2 (1.7%) 0.0 0.0 0.0 0.893
Acquired immunodefi-
ciency syndrome 0.0 1 (3.4%) 0.0 0.0 0.349
Asthma 1 (0.9 %) 0.0 0.0 1 (5.6%) 0.479
Hypothyroidism 3 (2.6%) 0.0 0.0 0.0 0.817
Celiac disease 1 (0.9%) 0.0 0.0 0.0 0.853
Antiphospholipid syndrome 0.0 1 (3.4%) 0.0 0.0 0.349
ACEI/ABR 25 (21.6%) 4 (13.8%) 2 (25%) 2 (11.1%) 0.566
Lipid-lowering agent 11 (9.5%) 1 (3.4%) 0.0 0.0 0.579
Antidepressant 8 (6.9%) 2 (6.9%) 0.0 1 (5.6%) 0.901
Beta-blocker 3 (2.6%) 7 (24.1%) 0.0 0.0 0.002
Omeprazole 5 (4.3%) 1 (3.4%) 1 (12.5%) 2 (11.1%) 0.352
Aspirin 4 (3.4%) 1 (3.4%) 0.0 0.0 0.882
Spironolactone 0.0 1 (3.4%) 0.0 0.0 0.320
Diuretic 12 (10.3%) 2 (6.9%) 0.0 0.0 0.700
Amiodarone 1 (0.9%) 0.0 0.0 0.0 0.746
Warfarin 0.0 1 (3.4%) 0.0 0.0 0.320
Antidiabetic agents 4 (3.4%) 1 (3.4%) 0.0 0.0 0.900
Other drugs 12 (10.3%) 3 (10.3%) 0.0 0.0 0.740
Consumption of alcoholic
  drinks
22 (19.0%) 9 (31.0%) 2 (25.0%) 5 (27.8%) 0.515
Smoking 8 (6.9%) 1 (3.4%) 0.0 2 (11.1%) 0.751
Physical activity 53 (45.7%) 15 (51.7%) 6 (75.0%) 10 (55.6%) 0.334
Benznidazole 38 (22,2%) 10(5,8%) 5 (2,9%) 6 (3,5%) 0,960
Positive PCR 63 (56.7%) 16 (55.2%) 6 (75.0%) 7 (43.8%) 0.578
Parasite load† 0.01 (0.09) 0.02 (0.12) 0.05 (8.63) 0.00 (0.01) 0.038
*Pearson chi-square tests with Monte Carlo correction for qualitative variables and Kruskal-Wallis test for quantitative variables. ACEI/ABR: 
angiotensin-converting enzyme inhibitors; HUB: Brasília University Hospital; PCR: polymerase chain reaction. †Quantitative evaluation of parasite 
load equivalent to number of parasites/100 ng DNA.
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patients, but this was benign or associated with aging, in 8 
(38.09%) with cardiac CD, 4 (23.53%) with digestive CD, 
and 4 (50%) with mixed CD. Cardiac variables determined 
by conventional echocardiography did not significantly differ 
(Table 3). Apical thrombus with apical aneurysms was found 
in only 2 (1.8%) of 164 patients in association with cardiac CD. 
Table 2 shows the findings of 158 (96%) of 164 patients who 
underwent qRT-PCR tests for T. cruzi DNA. The parasite load 
was positive in 63 (56.7%), 16 (55.2%), 7 (43.8%) and 6 (75%) 
patients with indeterminate, cardiac, digestive and mixed forms 
of CD, respectively. The amount of parasites significantly 
differed among CD classifications (Table 2), being The 
parasitic load was greater for the  mixed, than for the cardiac, 
indeterminate and digestive forms.
TABLE 3: Conventional echocardiographic variables at HUB, Brasília.
*Kruskal-Wallis tests. Abbreviations: DT: deceleration time; EF: ejection fraction; FAC: fractional area chan-ge; HUB: Brasília University Hospital; LA: left 
atrium; LV: left ventricle; RA: right atrium; RV: right ventricle; TAPSE: tricuspid annular plane systolic excursion; TE/RV: myocardial performance index of 
right ventricle; VEL: velocity; Vol, volume.
DISCUSSION  
The mean age of our study cohort was 45 years and women 
were predominant. Most participants had completed at least an 
elementary education, were employed in domestic or general 
services jobs, and resided in the Federal District. About 62% of 
them reported contact with the triatomine bug. As this cohort 
was derived mostly from an outpatient clinic, the predominance 
of females might be related to a greater demand for medical 
services by women, as determined by Bozelli et al.14, Vizzoni 
et al.15, and Martins-Melo et al. in a recent meta-analysis1. The 
age of our participants was similar to those reported by Bozelli 
et al.14 and Araújo et al.16, but differed from those described by 
Vizzoni et al.15, Alves et al.17 and Pereira et al.18, who reported 
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Indeterminate Cardiac Mixed Digestive
(n =114) (n = 25) (n = 8) (n = 17)
Median IQR Median IQR Median IQR Median IQR P*
LVEDV  (mL/m2) 27.81 3.08 27.37 4.48 26.97 2.53 26.72 5.46 0.168
 LA (mm/m2) 18.02 3.80 16.79 4.15 15.87 5.72 17.85 3.51 0.484
 RV (mm/m²) 14.55 4.12 14.31 5.17 14.19 5.17 14.17 5.61 0.836
TAPSE (cm) 2.51 0.65 2.27 0.43 2.72 0.79 2.56 0.48 0.070
 Color Doppler S Wave (cm/s) 13.40 2.72 13.60 2.45 13.40 2.85 13.45 2.90 0.776
RA VOL (mL/m2) 17.20 8.15 14.80 11.10 14.80 9.33 16.60 5.23 0.663
TEI / RV 0.39 0.33 0.41 0.35 0.43 0.39 0.40 0.38 0.750
FAC RV % 0.44 0.18 0.41 0.11 0.34 0.31 0.46 0.21 0.495
LA Vol (mL/m²) 18.75 9.23 17.63 6.78 23.90 11.68 20.73 8.85 0.578
LVEF % 70.16 10.52 69.90 12.61 70.28 8.80 67.53 13.07 0.839
LV MASS (g/m²) 71.30 25.95 65.70 29.80 60.45 20.75 64.15 22.23 0.230
Mitral flow E velocity (cm/s) 77.90 28.70 82.30 25.70 90.80 26.85 79.90 24.80 0.335
Mitral flow A velocity (cm/s) 58.70 22.37 63.20 23.10 51.35 53.38 60.00 34.50 0.762
S Vel (cm/s) 7.90 1.90 7.90 1.10 8.80 1.50 7.90 1.60 0.373
A' Vel (cm/s) 8.90 2.80 9.30 2.15 8.55 1.10 8.90 2.20 0.630
E’ Vel septal 10.00 3.40 9.70 2.80 11.00 3.18 9.40 3.65 0.537
E/A RATIO 1.33 0.68 1.30 0.63 1.42 0.94 1.57 0.77 0.439
Average e’' (cm/s) 11.15 3.57 11.05 4.50 11.72 4.86 9.97 2.72 0.544
Mitral DT (ms) 0.19 0.07 0.20 0.08 0.18 0.07 0.20 0.059 0.297
E/e’ (average e’) 7.08 2.80 7.35 3.33 7.98 4.60 8.10 2.98 0.610
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a more advanced group. We consider that this difference was 
due to the types of patients who use the HUB service. Most 
are referred from hemocenter screening; others are diagnosed 
during prenatal care and some are referred from primary care. 
Our patients had an average education duration of four 
years, and were thus better educated than those in previous 
studies (Table 1)19,20. 
Most patients recalled having been bitten by the triatomine 
bug, reinforcing the hypothesis of infection via vector 
transmission. These findings were similar to those published 
by others20.
Hypertension was the most frequent (21.6%) comorbidity 
which agrees with previous studies that found a 20%-25% 
prevalence of arterial hypertension in Brazil21-25. The second 
most common comorbidity was dyslipidemia, at 20.5%. The 
prevalence of dyslipidemia widely varies depending on the 
cultural and lifestyle habits of the population studied; for 
example, the estimated prevalence of dyslipidemia in the adult 
Brazilian population is 20%-30%26. Chronic diseases can 
lead to depression, and in CD, this association is attributed 
to psychological factors. However, Villar-Pereira et al. have 
associated immunological and neurochemical disorders with 
depressive manifestations in animal models27. Little is known 
about rates of depression among patients with CD. Osaki et al. 
identified symptoms of depression in 40.9% of 110 patients, 
particularly in those with heart disease28. Only 8% of our patients 
reported depression. This might be underestimated owing to the 
limitations of “self-referred” information derived from patients.
Overall, 24 (14.6%) of our patients were treated with 
benznidazole, which was lower than that previously reported29-32. 
This could be explained by low acceptance of or compliance 
with recommended treatment or because the present study 
involved outpatients who were in routinely followed up as part 
of the HUB service.
The distribution of the clinical CD forms among patients 
at HUB has not been previously reported. Most of our patients 
were diagnosed with the indeterminate form of the disease 
(64.3%), which is in contrast to recently published findings14. 
This might have been because our cohort was derived from 
outpatient clinics and HUB is a referral center for CD in the 
Federal District that accepts patients referred after screening by 
Hemocentro, which is the blood bank in Brasília. 
An accurate way to evaluate amounts of protozoan DNA 
in the serum of individuals infected by T. cruzi is qRT-PCR. 
We found a statistically significant difference in parasitic load 
among different forms of CD using qRT-PCR. The parasitic 
load was significantly higher for the mixed, than the cardiac, 
indeterminate and digestive forms. This finding differs from 
previously published findings suggesting that the parasite 
load decreases with higher chronicity33. This finding should 
be carefully analyzed owing to the small sample size of the 
groups studied. One explanation for this could be the influence 
of treatment on parasite load. However, 34.5% of our study 
population was treated with BNZ and a significant difference 
among clinical forms was not found.
Echocardiography is a valuable tool for evaluating patients 
with CD, as it can assess cardiac function and structure, which 
complements information obtained by electrocardiography. 
Because ventricular segmental contractility in patients with CD 
is associated with disease progression, echocardiography has 
been routinely applied in survival studies34-38. Left ventricular 
apical aneurysms are found in about 2% of patients with CD, and 
in 24% of patients with electrocardiographic abnormalities34. 
Two (1.8%) of our patients had apical aneurysms and 33 (19.3%) 
had electrocardiographic abnormalities. However, these depend 
on the type of study and the predominant clinical forms. Other 
studies have generated different results; Pereira et al.18 and 
Andrade et al.35 respectively detected electrocardiographic 
abnormalities and changes in 48% and 10.8% of patients.
Aneurysms are associated with left ventricular thrombi 
and embolic stroke within two years of their detection. Apical 
aneurysms and intracavitary thrombi are the main factors 
associated with cerebrovascular ischemic events in patients with 
CD. Subclinical atherosclerosis assessed by carotid IMT does 
not appear to play a major role in the genesis of ischemic events 
in CD39,40. Therefore, these patients need rigorous follow-up 
using methods that can detect early changes, considering that 
the clinical behavior of indeterminate CD is heterogeneous, 
and factors associated with progression to more severe forms 
remain unknown. 
The present study characterized outpatients with CD 
treated at a referral university hospital, and highlighted female 
predominance, younger age, and a higher average level of 
education.
The present study is a preliminary investigation to determine 
the composition of a clinical cohort in which to evaluate the 
progression of CD to the cardiac form. We determined the 
characteristics of a population treated at a tertiary teaching 
hospital, which should contribute to the composition of samples 
in subsequent studies. All possible prognostic variables, such as 
treatment with specific medications, will be evaluated in such a 
clinical cohort. We highlighted the importance of the descriptive 
data presented in this study because the sample consisted 
predominantly of women diagnosed with the undetermined 
form of CD. A study of prognostic factors in specific groups 
is important to understand the progression of CD and to 
contribute to technological improvements in the detection of 
CD progression and treatment.
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